Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186,164,820
-
Total 13F shares
-
70,364,140
-
Share change
-
+3,917,191
-
Total reported value
-
$2,233,248,707
-
Put/Call ratio
-
86%
-
Price per share
-
$31.74
-
Number of holders
-
127
-
Value change
-
+$91,598,352
-
Number of buys
-
82
-
Number of sells
-
36
Institutional Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q2 2021
As of 30 Jun 2021,
Revolution Medicines, Inc. - Common Stock (RVMD) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,364,140 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, TRV GP III, LLC, VANGUARD GROUP INC, BlackRock Inc., BOXER CAPITAL, LLC, Column Group LLC, Cormorant Asset Management, LP, Farallon Capital Management LLC, and BVF INC/IL.
This page lists
127
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.